337 related articles for article (PubMed ID: 25418285)
1. Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?
Emami-Riedmaier A; Schaeffeler E; Nies AT; Mörike K; Schwab M
J Intern Med; 2015 Feb; 277(2):235-247. PubMed ID: 25418285
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.
Manolopoulos VG; Ragia G; Tavridou A
Pharmacogenomics; 2011 Aug; 12(8):1161-91. PubMed ID: 21843065
[TBL] [Abstract][Full Text] [Related]
3. New insights into antidiabetic drugs: Possible applications in cancer treatment.
Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Zarghami N
Chem Biol Drug Des; 2017 Dec; 90(6):1056-1066. PubMed ID: 28456998
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.
Daniels MA; Kan C; Willmes DM; Ismail K; Pistrosch F; Hopkins D; Mingrone G; Bornstein SR; Birkenfeld AL
Pharmacogenomics J; 2016 Oct; 16(5):399-410. PubMed ID: 27432533
[TBL] [Abstract][Full Text] [Related]
5. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
[TBL] [Abstract][Full Text] [Related]
6. Evolving therapeutic options for type 2 diabetes mellitus: an overview.
Guthrie RM
Postgrad Med; 2012 Nov; 124(6):82-9. PubMed ID: 23322141
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic studies update in type 2 diabetes mellitus.
Singh S; Usman K; Banerjee M
World J Diabetes; 2016 Aug; 7(15):302-15. PubMed ID: 27555891
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in diabetes: influence on therapy with oral antidiabetics.
Glamočlija U; Jevrić-Čaušević A
Acta Pharm; 2010 Dec; 60(4):387-406. PubMed ID: 21169132
[TBL] [Abstract][Full Text] [Related]
9. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of oral antidiabetic therapy.
Ordelheide AM; Hrabě de Angelis M; Häring HU; Staiger H
Pharmacogenomics; 2018 Apr; 19(6):577-587. PubMed ID: 29580198
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes and oral antihyperglycemic drugs.
Mizuno CS; Chittiboyina AG; Kurtz TW; Pershadsingh HA; Avery MA
Curr Med Chem; 2008; 15(1):61-74. PubMed ID: 18220763
[TBL] [Abstract][Full Text] [Related]
12. Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions.
Holstein A; Beil W
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):225-41. PubMed ID: 19331589
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics and personalized treatment of type 2 diabetes.
Semiz S; Dujic T; Causevic A
Biochem Med (Zagreb); 2013; 23(2):154-71. PubMed ID: 23894862
[TBL] [Abstract][Full Text] [Related]
14. Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
Fisman EZ; Motro M; Tenenbaum A
Adv Cardiol; 2008; 45():154-170. PubMed ID: 18230961
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
[TBL] [Abstract][Full Text] [Related]
17. China type 2 diabetes treatment status survey of treatment pattern of oral drugs users.
Ji L; Lu J; Weng J; Jia W; Tian H; Zhu D; Xing X; Guo L
J Diabetes; 2015 Mar; 7(2):166-73. PubMed ID: 24809622
[TBL] [Abstract][Full Text] [Related]
18. Precision medicine: The future in diabetes care?
Scheen AJ
Diabetes Res Clin Pract; 2016 Jul; 117():12-21. PubMed ID: 27329017
[TBL] [Abstract][Full Text] [Related]
19. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.
Rascati K; Richards K; Lopez D; Cheng LI; Wilson J
Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154
[TBL] [Abstract][Full Text] [Related]
20. [Drug treatment of type 2 diabetes].
Tielmans A; Laloi-Michelin M; Coupaye M; Virally M; Meas T; Guillausseau PJ
Presse Med; 2007 Feb; 36(2 Pt 2):269-78. PubMed ID: 17258675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
